P PRIMESTOCKFINDER.COM

BDX Stock Becton, Dickinson and Company

BUY US · NYSE
$196.39 -1.27% Prices as of close 2026-10-26

Recurring medical-device demand and renewed analyst optimism support dependable forward returns.

Future value: $194.08 (-1.18%) · 6-12 months · analyst consensus

Signal breakdown

  • ▸Recent upgrades and higher targets indicate improving institutional confidence.
  • ▸Above 50-day MA (+5.8%)
  • ▸Above 200-day MA — long-term uptrend
  • ▸Near 52-week high (94.4% of range) — strength
  • ▾Trading above its price target — limited upside

Is BDX a buy right now?

Trend: BDX is trading above the 50-day average (+5.80%), RSI 62 — neutral momentum, with a 3-month return of +18.07%.

Valuation & quality: Becton, Dickinson and Company trades on a trailing P/E of 45.7, forward P/E 14.8, PEG 1.11, price-to-book 2.19; fundamentals show net margin 4.2%, return on equity 6.6%, revenue growth 5.4% year on year.

Analyst consensus: 14 analysts have a mean 12-month price target of $195.57 (-0.4% vs the last close; range $165.00 – $225.00), consensus rating “buy”.

Income: trailing dividend yield 2.11%.

Our screen: BUY (score 2) — Recurring medical-device demand and renewed analyst optimism support dependable forward returns.

Computed from end-of-day data; not personal advice.

12-month price chart

200.4 140.7 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-09 → 2026-10-26 (USD). Range 140.7 – 200.4.

Monthly returns

Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
-10.90%-5.20%-1.30%+2.90%+9.40%+13.60%-4.80%+9.70%

Fundamentals

Market cap
$53.49B
P/E (ttm)
45.7
Forward P/E
14.8
EPS (ttm)
$4.30
Price / book
2.19
PEG
1.11
Beta
0.28
Net margin
4.2%
ROE
6.6%
Revenue growth
5.4%
Earnings growth
-31.4%
Revenue (ttm)
$22.48B
Free cash flow
$4.48B
Debt / equity
69%
Dividend yield
2.11%
52-wk range
$127.59 – $200.47
Volume
1,316,093
Avg volume (3m)
1,750,725

Analyst price target

Mean target
$195.57
Low
$165.00
High
$225.00
Analysts
14
Consensus
BUY

Technical signals

RSI (14)
61.9
vs 50-day MA
+5.80%
1-mo return
+6.84%
3-mo return
+18.07%
Volume z-score
-1.25

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.

Sector: Healthcare · Industry: Medical Instruments & Supplies · United States · 72,000 employees · Website

Related Health Care picks

BMRNBioMarin PharmaceuticaIONSIonis Pharmaceuticals,BSXBoston Scientific CorpSYKStryker CorporationUNHUnitedHealth Group IncHUMHumana Inc.BMYBristol-Myers Squibb CHNGEHinge Health, Inc.

Browse: all US stocks · Health Care picks · today's movers

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.